Jon Baden
Executive Director & Head of Precision Medicine Bristol Myers Squibb
Jonathan Baden is an accomplished Executive Director with a strong background in Solid Tumor Oncology Diagnostics at Bristol Myers Squibb. With extensive experience in biomarker development and molecular diagnostics, he has a proven track record of leading teams and managing complex projects within the life sciences sector. Jonathan’s career spans over two decades, during which he has held key roles in both large pharmaceutical companies and research institutions. His expertise in FDA regulatory processes and product development has significantly contributed to advancing diagnostic strategies in oncology. He is known for his strategic thinking and ability to foster collaboration across multidisciplinary teams. Jonathan is passionate about leveraging innovative technologies to improve patient outcomes and drive advancements in precision medicine. He holds degrees in Microbiology and Immunology, and Biotechnology, showcasing his strong academic foundation in the life sciences.
Seminars
- Determining how much molecular change justifies a switch when the scan still reads stable
- Weighing the risk of switching too early against the cost of waiting for radiographic confirmation
- Establishing what evidence oncologists and payers need before molecular progression becomes an accepted trigger
